Host cells and methods for production of isobutanol
First Claim
Patent Images
1. A recombinant host cell comprising an engineered isobutanol production pathway comprising:
- a. a heterologous polypeptide having ketol-acid reductoisomerase (KARI) activity, wherein said heterologous polypeptide having KARI activity comprises an amino acid sequence that is at least 95% identical to the amino acid sequence set forth in SEQ ID NO;
27 with the exception of at least four mutations selected from the group consisting of amino acid residues at positions corresponding to A41, Y53, S56, K57, S58, I86, N87, K90, T93, T131, T191, R227, and Q246 of the amino acid sequence of SEQ ID NO;
27; and
b. at least one host cell modification selected from the group consisting of eliminated aldehyde dehydrogenase expression or activity, wherein said host cell modification is a deletion of an endogenous polynucleotide encoding aldehyde dehydrogenase, and eliminated acetolactate reductase expression or activity, wherein said host cell modification is a deletion of an endogenous polynucleotide encoding acetolactate reductase.
2 Assignments
0 Petitions
Accused Products
Abstract
Provided herein are recombinant yeast host cells and methods for their use for production of isobutanol. Yeast host cells provided comprise an isobutanol biosynthetic pathway and at least one of reduced or eliminated aldehyde dehydrogenase activity, reduced or eliminated acetolactate reductase activity; or a heterologous polynucleotide encoding a polypeptide having ketol-acid reductoisomerase activity.
-
Citations
35 Claims
-
1. A recombinant host cell comprising an engineered isobutanol production pathway comprising:
-
a. a heterologous polypeptide having ketol-acid reductoisomerase (KARI) activity, wherein said heterologous polypeptide having KARI activity comprises an amino acid sequence that is at least 95% identical to the amino acid sequence set forth in SEQ ID NO;
27 with the exception of at least four mutations selected from the group consisting of amino acid residues at positions corresponding to A41, Y53, S56, K57, S58, I86, N87, K90, T93, T131, T191, R227, and Q246 of the amino acid sequence of SEQ ID NO;
27; andb. at least one host cell modification selected from the group consisting of eliminated aldehyde dehydrogenase expression or activity, wherein said host cell modification is a deletion of an endogenous polynucleotide encoding aldehyde dehydrogenase, and eliminated acetolactate reductase expression or activity, wherein said host cell modification is a deletion of an endogenous polynucleotide encoding acetolactate reductase. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 33, 34, 35)
-
-
31. A polypeptide comprising an amino acid sequence that is at least 95% identical to the amino acid sequence set forth in SEQ ID NO:
- 27 with the exception of at least four mutations selected from the group consisting of amino acid residues at positions corresponding to A41, Y53, S56, K57, S58, I86, N87, K90, T93, T131, T191, R227, and Q246 of the amino acid sequence of SEQ ID NO;
27, wherein said polypeptide has ketol-acid reductoisomerase (KARI) activity. - View Dependent Claims (32)
- 27 with the exception of at least four mutations selected from the group consisting of amino acid residues at positions corresponding to A41, Y53, S56, K57, S58, I86, N87, K90, T93, T131, T191, R227, and Q246 of the amino acid sequence of SEQ ID NO;
Specification